Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Rare collarbone break study seeks answers from 30 patients

NCT ID NCT07414654

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviews medical records of about 30 adults who had surgery for a broken collarbone that didn't heal properly (nonunion). The goal is to see how often the bone heals after surgery and how patients recover. No new treatments or visits are involved—only existing data is used.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Retrospective, single-center study including adults (≥18 years) treated at CHU de Brest who underwent surgical management of clavicle nonunion (pseudarthrosis), aseptic or septic, between 01/01/2000 and 31/12/2024. Eligible cases have documented clinical and radiographic nonunion and sufficient perioperative records and imaging to assess outcomes. Patients who object to the reuse of their data, are under legal protection, are \<18 years old, have congenital or pathologic pseudarthrosis, or were managed without surgery are not included.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria (must meet all) : * Setting \& period: Managed at CHU de Brest (Orthopaedics-Traumatology) and operated for clavicle nonunion between 01/01/2000 and 31/12/2024. * Age: ≥ 18 years at the time of the index nonunion surgery. * Diagnosis: Clavicle pseudarthrosis (nonunion) documented in the record, defined as no clinical and radiographic union ≥6 months after the initial fracture, or radiographic signs of nonunion (e.g., gap, no bridging callus, sclerotic ends) with compatible symptoms. * Index treatment: Surgical management of the pseudarthrosis (e.g., osteosynthesis with/without bone graft, vascularized graft, other reconstructive technique). * Minimum data available: Pre- and/or peri-operative imaging confirming nonunion and at least one postoperative clinical and/or radiographic assessment (any timing). * Scope: Aseptic and/or septic clavicle nonunions are eligible. Exclusion / non-inclusion criteria (not eligible) * Legal protection: Adults under legal protection (sauvegarde de justice/curatelle/tutelle). * Patient objection: Any opposition to the use of their data. * Age \< 18 years. * Non-surgical management only of the nonunion (conservative treatment without surgery). * Acute fractures (\<6 months) without nonunion criteria, or delayed union without pseudarthrosis criteria. * Pathologic fracture (tumor/metastasis) or congenital clavicle pseudarthrosis. * Care outside the study period and/or outside CHU de Brest. Exclusion after initial selection (screen-fail after chart review) * Insufficient documentation to evaluate exposure and/or the primary outcome: no usable pre- or post-op imaging and no postoperative follow-up available (immediate loss to follow-up). * Early death unrelated to the condition/surgery before any postoperative assessment. * Unclassifiable infection status: suspected infection without microbiologic confirmation and without a clear therapeutic strategy, preventing classification as septic vs aseptic. * Major ipsilateral concomitant trauma making functional scores uninterpretable (e.g., severe brachial plexus injury, major scapulothoracic stiffness, recent shoulder arthroplasty). * Unresolved duplicates/inconsistent identifiers (same patient-same clavicle).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Clavicle fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pseudarthrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chu Brest

    Brest, 29200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.